Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of June 9, 2025 • 3:51 PM ET

Date/Time Source News Release
05/28/2025 06:30 AM EDT GlobeNewswire Veru Reports Positive Safety Results from Phase 2b QUALITY Study: Enobosarm Added to Semaglutide Led to Greater Fat Loss, Preservation of Muscle, and Fewer Gastrointestinal Side Effects Compared to Semaglutide Alone
05/08/2025 09:25 AM EDT GlobeNewswire Veru Participates in a Virtual Investor KOL Connect Segment
05/08/2025 06:30 AM EDT GlobeNewswire Veru Reports Fiscal 2025 Second Quarter Financial Results and Clinical Program Progress
05/01/2025 08:30 AM EDT GlobeNewswire Veru to Report Fiscal 2025 Second Quarter Financial Results on May 8
04/16/2025 08:30 AM EDT GlobeNewswire Veru to Present at the 2nd Annual GLP-1-Based Therapeutics Summit
03/31/2025 08:30 AM EDT GlobeNewswire Veru to Participate in Fireside Chat at the Jones Healthcare and Technology Innovation Conference
02/13/2025 06:30 AM EST GlobeNewswire Veru Reports Fiscal 2025 First Quarter Financial Results and Clinical Program Progress
02/06/2025 08:30 AM EST GlobeNewswire Veru to Report Fiscal 2025 First Quarter Financial Results on February 13, 2025
02/04/2025 08:30 AM EST GlobeNewswire Veru to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference
01/27/2025 06:30 AM EST GlobeNewswire Veru Announces Positive Topline Data from Phase 2b QUALITY Clinical Study: Enobosarm Preserved Lean Mass in Patients Receiving WEGOVY® (Semaglutide) for Weight Reduction
Page

Additional News

As of June 9, 2025 • 3:51 PM ET

Date/Time Source News Release
05/30/2025 01:34 AM EDT SeekingAlpha Tootsie Roll among names set to join Russell 3000 Index, Growgeneration, Veru set to leave
05/30/2025 01:16 AM EDT SeekingAlpha Beyond Meat, Plby among consumer staple names set to join Russell Microcap Index, Veru, Vitals Farms to leave
05/28/2025 01:30 PM EDT PRISM News PRISM Mid-Day Movers: Weight Loss Innovation and Warrant Cancellation Drive Market Action
05/28/2025 09:54 AM EDT 24/7 Market News Biotech Today: From Sustainable Biomaterials to First-in-Class Therapies
05/26/2025 09:36 PM EDT SeekingAlpha Veru: Saving Muscle Mass Amidst The GLP-1 Drug Boom
05/15/2025 05:54 PM EDT SeekingAlpha Zealand CEO: Oral weight loss meds are not the future for treating obesity
05/08/2025 12:42 PM EDT SeekingAlpha Veru signals Q3 2025 regulatory clarity for enobosarm Phase 3 trial
05/08/2025 12:42 PM EDT SeekingAlpha Veru Inc. (VERU) Q2 2025 Earnings Call Transcript
05/08/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Thursday, May 8th, 2025
05/08/2025 06:31 AM EDT SeekingAlpha Veru GAAP EPS of -$0.05 beats by $0.01, revenue of $3.93M
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.